140 related articles for article (PubMed ID: 38845281)
1. Drug-coated balloons for coronary artery disease: An updated review with future perspectives.
Bhogal S; Hill AP; Merdler I; Wermers JP; Ben-Dor I; Waksman R
Cardiovasc Revasc Med; 2024 May; ():. PubMed ID: 38845281
[TBL] [Abstract][Full Text] [Related]
2. Results of paclitaxel-drug-coated balloons (Pantera Lux) for coronary in-stent restenosis: Italian experience from REGistry of Paclitaxel Eluting Balloon in ISR study.
Galli S; Troiano S; Tespili M; Ielasi A; Niccoli G; Sommariva L; Amico F; Pasquetto G; Ceravolo R; Forlani D; Contarini M; Del Maestro M; Montorsi P
J Cardiovasc Med (Hagerstown); 2021 Jun; 22(6):469-477. PubMed ID: 33896930
[TBL] [Abstract][Full Text] [Related]
3. DCBs as an adjuvant tool to DES for very complex coronary lesions.
Chaddad R; El-Mokdad R; Lazar L; Cortese B
Rev Cardiovasc Med; 2022 Jan; 23(1):13. PubMed ID: 35092205
[TBL] [Abstract][Full Text] [Related]
4. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Follow-Up After Treatment of Drug-Eluting Stent Restenosis and De Novo Lesions Using SeQuent Please Paclitaxel-Coated Balloons.
Zhang D; Sun Y; Liu X; Liu F; Cheng Y; Ma X; Zhao Y; Zhou Y
Angiology; 2019 May; 70(5):414-422. PubMed ID: 30384776
[TBL] [Abstract][Full Text] [Related]
6. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
[TBL] [Abstract][Full Text] [Related]
7. The factors influencing the efficiency of drug-coated balloons.
Cao Z; Li J; Fang Z; Feierkaiti Y; Zheng X; Jiang X
Front Cardiovasc Med; 2022; 9():947776. PubMed ID: 36312265
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.
Cortese B; Testa G; Rivero F; Erriquez A; Alfonso F
JACC Cardiovasc Interv; 2023 May; 16(9):1054-1061. PubMed ID: 37164603
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
[TBL] [Abstract][Full Text] [Related]
10. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
[TBL] [Abstract][Full Text] [Related]
11. Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis.
Clever YP; Cremers B; von Scheidt W; Böhm M; Speck U; Scheller B
Clin Res Cardiol; 2014 Jan; 103(1):21-7. PubMed ID: 24072418
[TBL] [Abstract][Full Text] [Related]
12. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ
JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S
Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486
[TBL] [Abstract][Full Text] [Related]
14. Systematic Scoring Balloon Lesion Preparation for Drug-Coated Balloon Angioplasty in Clinical Routine: Results of the PASSWORD Observational Study.
Bonaventura K; Schwefer M; Yusof AKM; Waliszewski M; Krackhardt F; Steen P; Ocaranza R; Zuhdi AS; Bang LH; Graf K; Böck U; Chin K
Adv Ther; 2020 May; 37(5):2210-2223. PubMed ID: 32274746
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
Chen Y; Gao L; Qin Q; Chen S; Zhang J; Chen H; Wang L; Jin Z; Zheng Y; Zhang Z; Li H; Li X; Fu G; Chen L; Sun Z; Wang Y; Jin Q; Cao F; Guo J; Zhao Y; Guan C; Li W; Xu B;
JACC Cardiovasc Interv; 2018 Dec; 11(23):2368-2377. PubMed ID: 30522665
[TBL] [Abstract][Full Text] [Related]
16. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
Kook H; Joo HJ; Park JH; Hong SJ; Yu CW; Lim DS
BMC Cardiovasc Disord; 2020 Feb; 20(1):83. PubMed ID: 32070287
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study.
Pan L; Lu W; Han Z; Pan S; Wang X; Shan Y; Wang X; Zheng X; Li R; Zhou Y; Qin P; Shi Q; Zhou S; Zhang W; Guo S; Zhang P; Qin X; Sun G; Qin Z; Huang Z; Qiu C
Clin Res Cardiol; 2022 Jul; 111(7):732-741. PubMed ID: 34313800
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Revascularization at 10 Years After Percutaneous Treatment of Drug-Eluting Stent Restenosis.
Koch T; Lenz T; Rheude T; Cassese S; Kazazi M; Xhepa E; Kessler T; Wiebe J; Ferenc M; Laugwitz KL; Joner M; Schunkert H; Kastrati A; Kufner S
JACC Cardiovasc Interv; 2024 Jan; 17(1):1-13. PubMed ID: 37902151
[TBL] [Abstract][Full Text] [Related]
20. Drug-Coated Balloons in the Management of Coronary Artery Disease.
Korjian S; McCarthy KJ; Larnard EA; Cutlip DE; McEntegart MB; Kirtane AJ; Yeh RW
Circ Cardiovasc Interv; 2024 May; 17(5):e013302. PubMed ID: 38771909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
